首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Acta haematologica

缩写:ACTA HAEMATOL-BASEL

ISSN:0001-5792

e-ISSN:1421-9662

IF/分区:2.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1781
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xiaoyong Chen,Jialing Lu,Junjie Hou et al. Xiaoyong Chen et al.
Introduction: Acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia, typically presents with severe bleeding. However, the occurrence of APL with isolated myeloid sarcoma (MS) as the sole initial present...
Eva Desbrousses,Tifenn Charbonnel,Flavie Arbion et al. Eva Desbrousses et al.
Introduction Severe aplastic anemia (SAA) is a bone marrow failure disorder characterized by profound pancytopenia associated with a high risk of infection and bleeding. Case Presentation We report a case of a 19-year-old patient with a his...
Dae-Ho Choi,Jun Ho Jang,Chul Won Jung Dae-Ho Choi
Introduction: Treatment-free remission (TFR) is an established goal for patients with chronic myeloid leukemia in chronic phase (CML-CP) who achieve sustained deep molecular response (DMR) on tyrosine kinase inhibitor (TK...
Ilana Levy Yurkovski,Sharon Peleg-Nesher,Gabriel Pazooky et al. Ilana Levy Yurkovski et al.
Background: Sexual dysfunction and intimacy concerns are common in cancer but under-assessed in hematologic malignancies, including multiple myeloma (MM). MM-specific disease burden may compound age-related sexual dysfunc...
Yuxiu Xu,Xiaoli Sun,Jing Yang et al. Yuxiu Xu et al.
Background: Multiple myeloma (MM) remains an incurable hematological malignancy with heterogeneous outcomes, necessitating the identification of novel prognostic markers for improved patient stratification and treatment. ...
Wei Zhang,Wen Yan,Mengyun Chen et al. Wei Zhang et al.
Improvement in progression-free survival (PFS) is increasingly used by health authorities for cancer drug approvals. We analyzed 106 randomized controlled trials (RCTs) with positive PFS outcomes published in JAMA Oncology, Lancet Oncology,...
Konstantinos Tsiotsios,Sotirios Spyridon Vamvakas,Vasiliki Labropoulou et al. Konstantinos Tsiotsios et al.
Introduction Patients with homozygous β-thalassemia show continuously improved survival, which has contributed to the development of kidney complications, predominantly expressed as increased albuminuria. In particular, patients with trans...
Qili Yu,Jingni Cao,Yixia Chen et al. Qili Yu et al.
Background: Second-generation FLT3 inhibitors have demonstrated clinical efficacy in FLT3-mutated acute myeloid leukemia (AML), although results across randomized trials remain inconsistent. This meta-analysis aimed to ev...
Edmond Chiche,Caroline Fileni,Sarah Bonnet et al. Edmond Chiche et al.
Acute myeloid leukemia (AML) post myeloproliferative neoplasm (MPN) have very poor prognosis and are often excluded from most clinical trials. We retrospectively collected data from 166 patients, including 156 with available treatment data ...
Johanna Vikkula,Kari Remes,Outi Laatikainen et al. Johanna Vikkula et al.
Objectives: This study aimed to characterize multiple myeloma (MM) patients at the first relapse and examine treatment outcomes. Methods: ...